Assessment of KAN-101 in Celiac Disease (ACeD)
Public ClinicalTrials.gov record NCT04248855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Patients With Celiac Disease (ACeD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A safety study of KAN-101 in patients with celiac disease. The study has two parts: 1. Part A - first in human study in which patients receive a single dose of KAN-101 2. Part B - patients will receive three doses of either KAN-101 or placebo
Study identification
- NCT ID
- NCT04248855
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 20, 2020
- Primary completion
- Oct 7, 2021
- Completion
- Oct 7, 2021
- Last update posted
- Aug 5, 2024
2020 – 2021
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials | Anaheim | California | 92801 | — |
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Innovative Medical Research of South Florida | Aventura | Florida | 33180 | — |
| GCP Research | St. Petersburg | Florida | 33705 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| Parexel International- EPCU Baltimore | Baltimore | Maryland | 21225 | — |
| West Michigan Clinical Research Center | Wyoming | Michigan | 49519 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Celiac Disease Center at Columbia University | New York | New York | 10032 | — |
| North Carolina Clinical Research | Raleigh | North Carolina | 27607 | — |
| Aventiv Research | Columbus | Ohio | 43213 | — |
| WR-ClinSearch, LLC | Chattanooga | Tennessee | 37421 | — |
| Advanced Clinical Research | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04248855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2024 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04248855 live on ClinicalTrials.gov.